Type segmentation of the oral consumable market distinguishes four primary categories: pharmaceutical oral dosage forms, over‑the‑counter (OTC) remedies, nutraceuticals, and functional oral foods. Pharmaceutical forms—tablets, capsules, and liquid suspensions—are regulated products that account for roughly 40 % of total revenue, driven by chronic disease management and high‑margin prescription volumes. OTC remedies, including analgesic lozenges and antacids, contribute about 25 % as they capture price‑sensitive consumers seeking self‑medication. Nutraceuticals, defined as bioactive compounds such as vitamins, minerals, and herbal extracts, represent approximately 20 % of the market, reflecting growing consumer interest in preventive health. Functional oral foods—fortified chewing gums, probiotic lozenges, and nutritionally enriched beverages—make up the remaining 15 %, supported by innovation in delivery technology and convenience. Together, these type segments form the market taxonomy that underpins the overall oral consumable market size.